SPOTLIGHT ON STEM CELLS

Read about recent promising developments in two different clinical trials testing how stem cells can be used to fight blindness

Finish What We Started

FINISH WHAT WE STARTED

Help us Finish What We Started to ensure that all research the Foundation has committed to supporting in 2014 receives its funding - donate today!

Harnessing the Power of Omega-3 Fatty Acids

Foundation-funded study suggests that patients with age-related macular degeneration (AMD) should be taking omega-3 supplements.

WHY DO PHOTORECEPTORS DIE?

Read more about Dr. Michel Cayouette's incredible discovery that may hold the key to photoreceptor protection.

Research News

October 29, 2014 - Stem cell therapies are in the spotlight and everyone is watching the eye 
Learn about recent promising developments in two different clinical trials testing how stem cells can be used to fight blindness.

October 29, 2014 - Spotlight on Stem Cells: Interview with Dr. Saeed Khalili, BMO Postdoctoral Fellow in Retinal Research 
Stem cell scientist, Dr. Khalili, shares his personal insights about the recent developments in stem cell therapeutics.  

October 22, 2014 - Harnessing the Power of Omega-3 Fatty Acids to Fight Age-Related Macular Degeneration
A new Foundation-funded study shows that omega-3 fatty acid supplements can help wet AMD patients who are also receiving anti-VEGF injections.

October 16, 2014 - Regenerative Medicine Milestone
Advanced Cell Technology (ACT), an early leader in the field of regenerative medicine, recently published data in The Lancet that shows positive results from its ongoing stem cell transplantation trial. 

October 15, 2014 - Why do photoreceptors die? New study reveals important clues.  
New research by Dr. Michel Cayouette  sheds light on the mechanisms that underlie photoreceptor degeneration.  

October 14, 2014 - A New Kind of Vision: The Bionic Eye 
Today is a very exciting day at the Foundation Fighting Blindness because we are finally able to start sharing stories from the first Canadian patients to receive the Argus II implant, which used our valuable patient registry to identify the pioneering candidates: Orly Shamir and Ian Nichols. 

September 17, 2014 Discovery paves the road for new treatments to prevent blindness in babies  
An exciting new discovery by Foundation Fighting Blindness funded scientist, Dr. Jean-Sébastien Joyal and colleagues, opens the door to new treatments for retinopathy of prematurity.    

September 17, 2014 - Can stem cells be used to treat age-related macular degeneration? 
The world is watching after a woman in her 70s underwent a groundbreaking surgery in Japan. 

September 9, 2014 - Understanding the Link Between Protein Folding and Retinitis Pigmentosa
Recognized as the "American Nobels," the Lasker Awards are a highly prestigious honor in medicine and science. This year, the Basic Medical Research recipients were honoured for their transformative studies of the cellular quality-control system: the unfolded protein response (UPR). Disruptions to UPR are thought to play a critical role in neurodegenerative diseases, including retinitis pigmentosa (RP).

August 28, 2014 - New Findings on an Eye Drop to Treat Wet Age-Related Macular Degeneration
Squalamine eye drops may make current wet AMD treatments more effective, but the eye drops are unlikely to replace treatments by drug injections into the eye.

July 13, 2014 - MUHC researcher unveils novel treatment for a form of childhood blindness
An international research project, led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, reports that a new oral medication is showing significant progress in restoring vision to patients with Leber congenital amaurosis (LCA).

June 17, 2014 - Eight New Sight-Saving Research Projects
With your support, the Foundation Fighting Blindness is funding new research projects to better understand and treat age-related macular degeneration, retinitis pigmentosa, Leber congenital amaurosis and other blinding retinal diseases.

May 27, 2014 - Update on the RPE65 Gene Therapy Trials
A phase III trial for this type of Leber congenital amaurosis is now underway. 

Association for Research in Vision and Ophthalmology
Conference Coverage 2014

The annual ARVO meeting is the world's largest conference for vision research. It is being held this year in Orlando, Florida. We'll provide updates throughout the meeting.

May 8, 2014 - Potential Therapy to Slow Retinal Vision Loss
Promising signs of advances towards a sight protecting therapy for retinitis pigmentosa

 

May 7, 2014 - Valproic Acid as a Treatment for Retinitis Pigmentosa
Early trials show some visual improvements, but the treatmetn may only be appropriate for some types of RP.

May 6, 2014 - Genetic Testing and Retinitis Pigmentosa
Dr. Robert Koenekoop and his colleagues present information about a new screening panel for retinitis pigmentosa

May 6, 2014 - The Long-Term Treatment of Wet AMD
A closer look at the outcomes for people receiving wet AMD injections over many years

May 4, 2014 - One Year Results of the Choroideremia Gene Therapy Trial Presented
British scientists present data from this ongoing trial

April 15, 2014 - Trial of Treatment to Slow Retinitis Pigmentosa Vision Loss Begins in Italy
The eye drop uses a nerve growth factor to protect photoreceptors.

March 31, 2014 - Geneticist's sight-saving contributions recognized
Dr. Jane Green received the Order of Newfoundland and Labrador

March 25, 2014 - A Link between Exercise and Vision Health
American scientists make the first report of simple exercise having a direct effect on retinal health and vision.

Feb 21, 2014 - New Compound May be the Basis of a Promising Drug to Reverse Retinal Blindness
California researchers invent a new "photoswitch," which may give light-sensing capacity to retinal nerve cells potentially restoring vision to people with advanced retinal degenerative diseases.

Feb 5, 2014 - Testing the Safety of Induced Stem Cell Therapies
Cells derived from induced pluipotent stem cells will soon be used in a clinical trial for dry age-related macular degeneration and may be used for other conditions as well. How are scientists assessing the risks?  

Jan 16, 2014 - First gene therapy results for choroideremia suggest cautious optimism
Of first six patients treated in the British gene therapy trial for choroideremia, the two most visually impaired experience the most strikingly positive results.

Jan 8, 2014 - Allergies may protect against age-related macular degeneration
In a new, and unexpected research finding people with a history of allergies may be less likely to have AMD.

 

Donations to the Foundation Fighting Blindness support research teams across Canada. See our annual wrap-up of Ten 2013 Research Discoveries.

2013 Research News Archive / 2012 Research News Archive

You can help – support us today!

Privacy Policy | Accessibility Policy